CLDX (Celldex Therapeutics Inc) Sof foyda

CLDX (Celldex Therapeutics, Inc.) - kompaniyaning tovar belgisi

Celldex Therapeutics (CLDX) dermatit bilan kasallangan bemorlarni nishonga olgan holda, teri allergiyalariga qarshi kurashish uchun antitanachalar ishlab chiqadi. Biznes barzolitinibning ishga tushirilishi va yallig'lanish terapiyasi uchun mast hujayra retseptorlarini o'rganishga tayanadi. Operatsion zararlarga qaramay, likvidlik saqlanib qolmoqda, garchi muvaffaqiyat tartibga soluvchi organlarning tasdig'iga bog'liq bo'lsa-da. Kompaniyaning narx harakatlari grafigi ushbu omillarni tasdiqlaydi va foyda ko'rsatkichi -0.30 darajasida turibdi.

CLDX (Celldex Therapeutics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

Celldex Therapeutics, Inc. (CLDX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Celldex Corp|CLDX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Celldex Corp|CLDX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Celldex Therapeutics|CLDX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi celldex.com|CLDX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Celldex Therapeutics|CLDX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Celldex Therapeutics Inc|CLDX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Celldex Corp|CLDX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Celldex Therapeutics|Shoshilinch likvidlik celldex.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CLDX - Sof foyda
Kompaniyaning jamlanma tahlili:Celldex Therapeutics
Celldex asosiy tovari

Ushbu ko'rsatkich biznesning haqiqiy hayotiy qobiliyatini baholash uchun bozor shovqinlarini filtrlagan holda kunlik sof pul oqimini kuzatadi. Ushbu tendentsiyani tahlil qilish aktivlarning haddan tashqari qiziganini o'z vaqtida aniqlash va tebranishlar risklarini minimallashtirish imkonini beradi. Ushbu grafikda Celldex Therapeutics (CLDX) ning hisobotdagi daromadlari kompaniyaning haqiqiy moliyaviy barqarorligini vizuallashtiradi. Celldex Therapeutics (CLDX) uchun ushbu metrika rivojlanish bosqichini aks ettiradi, chunki maqsadli dori vositalari hali monetizatsiya bosqichiga yetib kelmagan.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Aurinia Pharmaceuticals Inc. (AUPH) - Kompaniyaning sof foydasi|Sof daromad BioCryst Pharmaceuticals, Inc.|Sof daromad VERA|Sof foyda Dianthus Corp|Kompaniyaning sof foydasi Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|Nektar Corp (NKTR) - Sof daromad|UPB: Sof foyda|Kompaniyaning sof daromadi zenasbio.com (ZBIO)|Kompaniyaning sof foydasi Immunome|Kompaniyaning sof foydasi GOSS|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|Kompaniyaning sof foydasi SEPN (Septerna Pharma)|Sof foyda PVLA (Pieris Pharmaceuticals)|SVRA: Kompaniya foydasi|Rigel Pharmaceuticals, Inc. - Sof foyda|Kompaniyaning sof daromadi AnaptysBio Inc|ATXS (Astria Pharma) - Sof daromad|Kompaniya foydasi ENGN|Sof daromad RAPT|JBIO: Yakuniy foyda|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|Soliqlar to‘langandan keyingi foyda KYTX|Sof foyda TLSA (Tiziana Life Sciences PLC)|Yakuniy foyda CABA|Ventyx Biosciences - Sof foyda|Kompaniyaning sof daromadi theratech.com|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Eledon Pharmaceuticals Inc. - Yakuniy foyda|AGEN (Agenus Inc) - Sof foyda|Sof foyda Climb Bio, Inc|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR: Soliqdan keyingi foyda|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|STTK: Sof daromad|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|IMUX: Soliqlar to‘langandan keyingi foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Kompaniyaning sof foydasi Celularity CELU|Sof moliyaviy natija inmunebio.com (INMB)|Barinthus Biotherapeutics plc - Sof foyda|Kezar Life Sciences Inc. (KZR) - Sof daromad|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|AKTX (Akari Therapeutics, Plc) - Kompaniyaning sof foydasi|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Kompaniya foydasi QTTB (Q32 Bio Corp)|Sof daromad GOVX (GeoVax)|Edesa Biotech Inc - Kompaniya foydasi|Kompaniyaning sof foydasi iBio Corp IBIO|CARM (Carisma Therapeutics Inc) - Soliqdan keyingi foyda|XTL Biopharmaceuticals - Sof foyda|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi